{"id":168,"date":"2026-09-22T13:09:18","date_gmt":"2026-09-22T13:09:18","guid":{"rendered":"https:\/\/funny-fermi.104-248-174-66.plesk.page\/?page_id=168"},"modified":"2026-10-29T18:08:20","modified_gmt":"2026-10-29T18:08:21","slug":"glioblastoma","status":"publish","type":"page","link":"https:\/\/funny-fermi.104-248-174-66.plesk.page\/fr\/disease-info\/glioblastoma\/","title":{"rendered":"Glioblastome"},"content":{"rendered":"<main id='oxy-main'><div class=\"oxy-container-168-254 oxy-container od-page-disease-info-glioblastoma\"><div class=\"oxy-container-168-253 oxy-container od-fx-793346c73\"><section class=\"oxy-container-168-267 oxy-container od-hero\" aria-labelledby=\"disease-title\"><div class=\"oxy-container-168-266 oxy-container od-container\"><div class=\"oxy-container-168-257 oxy-container od-hero-heading\"><div class=\"oxy-svg-icon2-168-255 oxy-svg-icon2 od-disease-hero-icon\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M12 5a3 3 0 1 0-5.997.125 4 4 0 0 0-2.526 5.77 4 4 0 0 0 .556 6.588A4 4 0 1 0 12 18Z\"><\/path><path d=\"M12 5a3 3 0 1 1 5.997.125 4 4 0 0 1 2.526 5.77 4 4 0 0 1-.556 6.588A4 4 0 1 1 12 18Z\"><\/path><path d=\"M15 13a4.5 4.5 0 0 1-3-4 4.5 4.5 0 0 1-3 4\"><\/path><path d=\"M17.599 6.5a3 3 0 0 0 .399-1.375\"><\/path><path d=\"M6.003 5.125A3 3 0 0 0 6.401 6.5\"><\/path><path d=\"M3.477 10.896a4 4 0 0 1 .585-.396\"><\/path><path d=\"M19.938 10.5a4 4 0 0 1 .585.396\"><\/path><path d=\"M6 18a4 4 0 0 1-1.967-.516\"><\/path><path d=\"M19.967 17.484A4 4 0 0 1 18 18\"><\/path><\/svg>\n<\/div><h1 class=\"oxy-text-168-256 oxy-text od-hero-title\" id=\"disease-title\">\nGlioblastoma\n<\/h1><\/div><p class=\"oxy-text-168-258 oxy-text od-hero-lead od-disease-hero-lead\">\nGlioblastoma is one of the most challenging brain tumours diagnosed in adults. Information and support are available for patients and families at every stage.\n<\/p><p class=\"oxy-text-168-259 oxy-text od-hero-copy od-disease-hero-copy\">\nGlioblastoma (GBM) is a fast-growing type of brain cancer and the most common form of aggressive brain cancer in adults. Standard treatment typically includes surgery followed by radiotherapy and chemotherapy, and an active research community continues to investigate new therapeutic approaches.\n<\/p><div class=\"oxy-container-168-262 oxy-container od-hero-actions\"><a class=\"oxy-text-link-168-260 oxy-text-link od-button od-button--accent od-button--borderless od-careers-hero-action\" href=\"\/patient-support-groups\/\" target=\"_self\">\nFind a Support Group\n<\/a><a class=\"oxy-text-link-168-261 oxy-text-link od-button od-button--outlined-light\" href=\"\/products\/\" target=\"_self\">\nView Our Products\n<\/a><\/div><button class=\"oxy-container-link-168-265 oxy-container-link od-hero-back\" target=\"_self\" data-interactions=\"[{&quot;trigger&quot;:&quot;click&quot;,&quot;prevent_default&quot;:true,&quot;actions&quot;:[{&quot;name&quot;:&quot;javascript_function&quot;,&quot;js_function_name&quot;:&quot;orphalanHeroBack&quot;}]}]\" id=\"disease-back\" type=\"button\" aria-label=\"Go back to the previous page\"><div class=\"oxy-svg-icon2-168-263 oxy-svg-icon2 od-hero-back-icon\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"m15 18-6-6 6-6\"><\/path><\/svg>\n<\/div><span class=\"oxy-text-168-264 oxy-text od-link-label\">\nBack\n<\/span><\/button><\/div><\/section><aside class=\"oxy-container-168-271 oxy-container od-disease-notice\" aria-label=\"Audience information\"><div class=\"oxy-container-168-270 oxy-container od-container od-disease-notice-container\"><div class=\"oxy-svg-icon2-168-268 oxy-svg-icon2 od-disease-notice-icon\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"><\/circle><line x1=\"12\" x2=\"12\" y1=\"8\" y2=\"12\"><\/line><line x1=\"12\" x2=\"12.01\" y1=\"16\" y2=\"16\"><\/line><\/svg>\n<\/div><p class=\"oxy-text-168-269 oxy-text od-disease-notice-copy\">\n<strong class=\"od-disease-notice-strong\">For patients, caregivers &amp; healthcare professionals.<\/strong> This page is intended for both patients and clinicians. Patients and caregivers: the information here is not a substitute for your doctor's advice \u2014 always speak with your care team. Healthcare professionals: please refer to the full SmPC before prescribing.\n<\/p><\/div><\/aside><section class=\"oxy-container-168-287 oxy-container od-section od-disease-section\" aria-labelledby=\"disease-overview-title\"><div class=\"oxy-container-168-286 oxy-container od-container\"><div class=\"oxy-container-168-285 oxy-container od-disease-overview-grid\"><img decoding=\"async\" class=\"oxy-image-168-272 oxy-image od-disease-photo\" src=\"https:\/\/funny-fermi.104-248-174-66.plesk.page\/wp-content\/uploads\/2026\/09\/young-child-therapy-battling-cancer_de_gauche-1.jpg\" alt=\"Patient receiving brain tumour therapy\" loading=\"lazy\"><div class=\"oxy-container-168-284 oxy-container od-disease-overview-copy\"><div class=\"oxy-container-168-273 oxy-container od-section-marker\" aria-hidden=\"true\"><\/div><h2 class=\"oxy-text-168-274 oxy-text od-section-title\" id=\"disease-overview-title\">\nWhat is Glioblastoma?\n<\/h2><div class=\"oxy-container-168-278 oxy-container od-disease-paragraphs\"><p class=\"oxy-text-168-275 oxy-text od-body od-iir-strong\">\nGlioblastoma is a fast-growing, cancerous brain tumour, classified as a Grade 4 glioma. A glioma is a type of tumour that develops from glial cells, which are the supporting cells that surround and protect nerve cells in the brain and spinal cord.\n<\/p><p class=\"oxy-text-168-276 oxy-text od-body od-iir-strong\">\nThe World Health Organisation (WHO) classifies gliomas into four grades, from Grade 1 (slower-growing) to Grade 4 (faster-growing and more aggressive), based on how the tumour cells behave. As a Grade 4 glioma, glioblastoma sits at the highest grade in this classification, reflecting its more aggressive nature. It is one of the more common types of brain tumour diagnosed in adults, representing approximately 45\u201350% of gliomas.\n<\/p><p class=\"oxy-text-168-277 oxy-text od-body od-iir-strong\">\nGlioblastoma can develop anywhere in the brain, though it most often affects the main part of the brain (the cerebrum). It is most commonly diagnosed in adults, with an average age at diagnosis of around 64, though it can occur at any age, and can spread into surrounding brain tissue.\n<\/p><\/div><article class=\"oxy-container-168-283 oxy-container od-disease-urgent\"><div class=\"oxy-container-168-281 oxy-container od-disease-urgent-heading\"><div class=\"oxy-container-168-279 oxy-container od-safety-bar\" aria-hidden=\"true\"><\/div><h3 class=\"oxy-text-168-280 oxy-text od-disease-urgent-title\">\nWhen to Seek Urgent Medical Attention\n<\/h3><\/div><p class=\"oxy-text-168-282 oxy-text od-body-small od-disease-urgent-copy\">\nNew or rapidly worsening headaches, unexplained seizures, progressive weakness in the limbs, speech difficulties, visual disturbances, or changes in personality or cognition should prompt urgent medical evaluation. Early assessment supports timely access to diagnosis and specialist care.\n<\/p><\/article><\/div><\/div><\/div><\/section><section class=\"oxy-container-168-309 oxy-container od-section od-disease-section\" aria-labelledby=\"disease-symptoms-title\"><div class=\"oxy-container-168-308 oxy-container od-container\"><header class=\"oxy-container-168-291 oxy-container od-disease-heading\"><span class=\"oxy-text-168-288 oxy-text od-disease-badge\">\nSIGNS &amp; SYMPTOMS\n<\/span><h2 class=\"oxy-text-168-289 oxy-text od-disease-title\" id=\"disease-symptoms-title\">\nSigns to Be Aware Of\n<\/h2><p class=\"oxy-text-168-290 oxy-text od-disease-heading-copy\">\nThe symptoms of glioblastoma depend on where the tumour is in the brain and how large it has grown. They can develop gradually over weeks or appear more suddenly.\n<\/p><\/header><div class=\"oxy-container-168-307 oxy-container od-disease-symptoms-grid\"><article class=\"oxy-container-168-296 oxy-container od-disease-card\"><div class=\"oxy-container-168-293 oxy-container od-disease-card-icon\"><div class=\"oxy-svg-icon2-168-292 oxy-svg-icon2 od-registry-pillar-symbol\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M22 12h-2.48a2 2 0 0 0-1.93 1.46l-2.35 8.36a.25.25 0 0 1-.48 0L9.24 2.18a.25.25 0 0 0-.48 0l-2.35 8.36A2 2 0 0 1 4.49 12H2\"><\/path><\/svg>\n<\/div><\/div><h3 class=\"oxy-text-168-294 oxy-text od-card-title\">\nHeadaches and Seizures\n<\/h3><p class=\"oxy-text-168-295 oxy-text od-body-small\">\nHeadaches are a common early symptom and often become more noticeable over time, particularly in the morning or when lying down. New seizures occur in around 20\u201330% of patients and can sometimes be the first sign that leads to a diagnosis. Nausea and vomiting can also occur, and may be related to increased pressure inside the skull caused by the tumour.\n<\/p><\/article><article class=\"oxy-container-168-301 oxy-container od-disease-card\"><div class=\"oxy-container-168-298 oxy-container od-disease-card-icon\"><div class=\"oxy-svg-icon2-168-297 oxy-svg-icon2 od-registry-pillar-symbol\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><rect width=\"16\" height=\"16\" x=\"4\" y=\"4\" rx=\"2\"><\/rect><rect width=\"6\" height=\"6\" x=\"9\" y=\"9\" rx=\"1\"><\/rect><path d=\"M15 2v2\"><\/path><path d=\"M15 20v2\"><\/path><path d=\"M2 15h2\"><\/path><path d=\"M2 9h2\"><\/path><path d=\"M20 15h2\"><\/path><path d=\"M20 9h2\"><\/path><path d=\"M9 2v2\"><\/path><path d=\"M9 20v2\"><\/path><\/svg>\n<\/div><\/div><h3 class=\"oxy-text-168-299 oxy-text od-card-title\">\nFocal Neurological Deficits\n<\/h3><p class=\"oxy-text-168-300 oxy-text od-body-small\">\nDepending on where the tumour is located in the brain, some people experience weakness, difficulty speaking or finding words, changes in sensation or problems with part of their vision. These changes tend to relate to the specific area of the brain affected, and may develop gradually or, in some cases, appear more suddenly.\n<\/p><\/article><article class=\"oxy-container-168-306 oxy-container od-disease-card\"><div class=\"oxy-container-168-303 oxy-container od-disease-card-icon\"><div class=\"oxy-svg-icon2-168-302 oxy-svg-icon2 od-registry-pillar-symbol\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M4 14a1 1 0 0 1-.78-1.63l9.9-10.2a.5.5 0 0 1 .86.46l-1.92 6.02A1 1 0 0 0 13 10h7a1 1 0 0 1 .78 1.63l-9.9 10.2a.5.5 0 0 1-.86-.46l1.92-6.02A1 1 0 0 0 11 14z\"><\/path><\/svg>\n<\/div><\/div><h3 class=\"oxy-text-168-304 oxy-text od-card-title\">\nCognitive &amp; Personality Changes\n<\/h3><p class=\"oxy-text-168-305 oxy-text od-body-small\">\nSome people notice difficulties with memory, concentration or planning and decision-making, which can be an early sign. Changes in personality or behaviour can also occur, and are sometimes mistaken for other causes before a diagnosis is made.\n<\/p><\/article><\/div><\/div><\/section><section class=\"oxy-container-168-329 oxy-container od-section od-disease-section od-disease-muted\" aria-labelledby=\"disease-treatment-title\"><div class=\"oxy-container-168-328 oxy-container od-container\"><header class=\"oxy-container-168-313 oxy-container od-disease-heading\"><div class=\"oxy-container-168-310 oxy-container od-section-marker\" aria-hidden=\"true\"><\/div><h2 class=\"oxy-text-168-311 oxy-text od-disease-title\" id=\"disease-treatment-title\">\nTreatment Approaches\n<\/h2><p class=\"oxy-text-168-312 oxy-text od-disease-heading-copy\">\nGlioblastoma is treated by a specialist team including brain surgeons, cancer doctors, radiotherapy specialists and other experts. The treatment plan is shaped by overall health, where the tumour is located and specific characteristics of the tumour.\n<\/p><\/header><div class=\"oxy-container-168-327 oxy-container od-disease-treatment-grid\"><article class=\"oxy-container-168-320 oxy-container od-disease-card\"><div class=\"oxy-container-168-315 oxy-container od-disease-card-icon od-disease-card-icon--teal\"><div class=\"oxy-svg-icon2-168-314 oxy-svg-icon2 od-registry-pillar-symbol\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M11 2v2\"><\/path><path d=\"M5 2v2\"><\/path><path d=\"M5 3H4a2 2 0 0 0-2 2v4a6 6 0 0 0 12 0V5a2 2 0 0 0-2-2h-1\"><\/path><path d=\"M8 15a6 6 0 0 0 12 0v-3\"><\/path><circle cx=\"20\" cy=\"10\" r=\"2\"><\/circle><\/svg>\n<\/div><\/div><h3 class=\"oxy-text-168-316 oxy-text od-card-title od-disease-treatment-title\">\nMultimodal Treatment Approach\n<\/h3><p class=\"oxy-text-168-317 oxy-text od-body-small od-iir-strong od-disease-treatment-copy\">\nTreatment typically begins with surgery to remove as much of the tumour as safely possible. This is usually followed by radiotherapy and chemotherapy (temozolomide), often given at the same time. <strong>Tumour tests<\/strong> carried out at diagnosis help the care team understand the tumour and guide the treatment plan. <strong>For patients who are older or whose health requires it<\/strong>, treatment may be adapted to suit individual needs.\n<\/p><p class=\"oxy-text-168-318 oxy-text od-body-small od-iir-strong od-disease-treatment-copy\">\nWhen glioblastoma returns after initial treatment, options may include further surgery where safe, more radiotherapy, a medicine called bevacizumab, a device that uses electrical fields to help slow tumour growth (tumour treating fields), and participation in clinical trials. Regular MRI scans are used to monitor how treatment is working.\n<\/p><p class=\"oxy-text-168-319 oxy-text od-body-small od-iir-strong\">\nTreatment decisions should always be made by a qualified healthcare professional based on the individual patient's circumstances.\n<\/p><\/article><article class=\"oxy-container-168-326 oxy-container od-disease-card\"><div class=\"oxy-container-168-322 oxy-container od-disease-card-icon od-disease-card-icon--teal\"><div class=\"oxy-svg-icon2-168-321 oxy-svg-icon2 od-registry-pillar-symbol\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M19 14c1.49-1.46 3-3.21 3-5.5A5.5 5.5 0 0 0 16.5 3c-1.76 0-3 .5-4.5 2-1.5-1.5-2.74-2-4.5-2A5.5 5.5 0 0 0 2 8.5c0 2.3 1.5 4.05 3 5.5l7 7Z\"><\/path><\/svg>\n<\/div><\/div><h3 class=\"oxy-text-168-323 oxy-text od-card-title od-disease-treatment-title\">\nTemozolomide\n<\/h3><p class=\"oxy-text-168-324 oxy-text od-body-small od-iir-strong od-disease-treatment-last\">\nTemozolomide is a chemotherapy medicine and a key part of the standard treatment for glioblastoma. It works by damaging the DNA of tumour cells, which stops them from dividing and growing.\n<\/p><a class=\"oxy-text-link-168-325 oxy-text-link od-button od-home-control od-home-control--navy od-home-control--regular od-disease-full-button\" href=\"\/pipeline\/#pipeline-0\" target=\"_self\">\nView in Our Pipeline\n<\/a><\/article><\/div><\/div><\/section><section class=\"oxy-container-168-367 oxy-container od-section od-disease-section od-disease-support\" aria-labelledby=\"disease-support-title\"><div class=\"oxy-container-168-366 oxy-container od-container\"><img decoding=\"async\" class=\"oxy-image-168-330 oxy-image od-disease-support-image\" src=\"https:\/\/funny-fermi.104-248-174-66.plesk.page\/wp-content\/uploads\/2026\/09\/Orphalan_web_image_5__1_.jpg\" alt=\"\" loading=\"lazy\"><div class=\"oxy-container-168-331 oxy-container od-disease-support-shade\" aria-hidden=\"true\"><\/div><div class=\"oxy-container-168-365 oxy-container od-disease-support-content\"><header class=\"oxy-container-168-335 oxy-container od-disease-heading od-disease-heading--light\"><div class=\"oxy-container-168-332 oxy-container od-section-marker\" aria-hidden=\"true\"><\/div><h2 class=\"oxy-text-168-333 oxy-text od-disease-title\" id=\"disease-support-title\">\nPatient Support and Community\n<\/h2><p class=\"oxy-text-168-334 oxy-text od-disease-heading-copy\">\nPatient associations and support groups are available for people affected by glioblastoma and their families. These organisations provide information and may offer opportunities to connect with others who have experience of the condition.\n<\/p><\/header><div class=\"oxy-container-168-360 oxy-container od-disease-associations\"><article class=\"oxy-container-168-341 oxy-container od-disease-association\"><h3 class=\"oxy-text-168-336 oxy-text od-disease-association-title\">\nAmerican Brain Tumour Association (ABTA)\n<\/h3><p class=\"oxy-text-168-337 oxy-text od-body-small od-disease-association-copy\">\nProvides comprehensive support, information and research funding for all brain tumour types, including glioblastoma \u2014 a trusted resource for patients and families in the USA.\n<\/p><a class=\"oxy-container-link-168-340 oxy-container-link od-disease-association-link\" href=\"https:\/\/www.abta.org\" target=\"_blank\" data-interactions=\"[{&quot;trigger&quot;:&quot;click&quot;,&quot;prevent_default&quot;:true,&quot;actions&quot;:[{&quot;name&quot;:&quot;javascript_function&quot;,&quot;js_function_name&quot;:&quot;orphalanDiseaseVisit1&quot;}]}]\" id=\"disease-association-1\" data-org-name=\"American Brain Tumour Association (ABTA)\" rel=\"noopener noreferrer\"><span class=\"oxy-text-168-338 oxy-text od-link-label\">\nVisit Website\n<\/span><div class=\"oxy-svg-icon2-168-339 oxy-svg-icon2 od-disease-external-icon\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M15 3h6v6\"><\/path><path d=\"M10 14 21 3\"><\/path><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"><\/path><\/svg>\n<\/div><\/a><\/article><article class=\"oxy-container-168-347 oxy-container od-disease-association\"><h3 class=\"oxy-text-168-342 oxy-text od-disease-association-title\">\nAlinoe (Association Lilloise de Neuro-Oncologie)\n<\/h3><p class=\"oxy-text-168-343 oxy-text od-body-small od-disease-association-copy\">\nA French neuro-oncology patient association providing support and information to patients and families affected by brain tumours, including glioblastoma.\n<\/p><a class=\"oxy-container-link-168-346 oxy-container-link od-disease-association-link\" href=\"https:\/\/www.alinoe.asso.fr\" target=\"_blank\" data-interactions=\"[{&quot;trigger&quot;:&quot;click&quot;,&quot;prevent_default&quot;:true,&quot;actions&quot;:[{&quot;name&quot;:&quot;javascript_function&quot;,&quot;js_function_name&quot;:&quot;orphalanDiseaseVisit2&quot;}]}]\" id=\"disease-association-2\" data-org-name=\"Alinoe (Association Lilloise de Neuro-Oncologie)\" rel=\"noopener noreferrer\"><span class=\"oxy-text-168-344 oxy-text od-link-label\">\nVisit Website\n<\/span><div class=\"oxy-svg-icon2-168-345 oxy-svg-icon2 od-disease-external-icon\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M15 3h6v6\"><\/path><path d=\"M10 14 21 3\"><\/path><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"><\/path><\/svg>\n<\/div><\/a><\/article><article class=\"oxy-container-168-353 oxy-container od-disease-association\"><h3 class=\"oxy-text-168-348 oxy-text od-disease-association-title\">\nDeutsche Hirntum\u043erhilfe eV\n<\/h3><p class=\"oxy-text-168-349 oxy-text od-body-small od-disease-association-copy\">\nGermany's leading brain tumour support organisation, offering information, counselling and community resources for patients and families affected by glioblastoma and other brain tumours.\n<\/p><a class=\"oxy-container-link-168-352 oxy-container-link od-disease-association-link\" href=\"https:\/\/www.hirntumorhilfe.de\" target=\"_blank\" data-interactions=\"[{&quot;trigger&quot;:&quot;click&quot;,&quot;prevent_default&quot;:true,&quot;actions&quot;:[{&quot;name&quot;:&quot;javascript_function&quot;,&quot;js_function_name&quot;:&quot;orphalanDiseaseVisit3&quot;}]}]\" id=\"disease-association-3\" data-org-name=\"Deutsche Hirntum\u043erhilfe eV\" rel=\"noopener noreferrer\"><span class=\"oxy-text-168-350 oxy-text od-link-label\">\nVisit Website\n<\/span><div class=\"oxy-svg-icon2-168-351 oxy-svg-icon2 od-disease-external-icon\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M15 3h6v6\"><\/path><path d=\"M10 14 21 3\"><\/path><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"><\/path><\/svg>\n<\/div><\/a><\/article><article class=\"oxy-container-168-359 oxy-container od-disease-association\"><h3 class=\"oxy-text-168-354 oxy-text od-disease-association-title\">\nIl Fondo di Gio ONLUS\n<\/h3><p class=\"oxy-text-168-355 oxy-text od-body-small od-disease-association-copy\">\nAn Italian non-profit foundation dedicated to funding research and supporting families affected by brain tumours.\n<\/p><a class=\"oxy-container-link-168-358 oxy-container-link od-disease-association-link\" href=\"https:\/\/www.ilfondodigio.it\" target=\"_blank\" data-interactions=\"[{&quot;trigger&quot;:&quot;click&quot;,&quot;prevent_default&quot;:true,&quot;actions&quot;:[{&quot;name&quot;:&quot;javascript_function&quot;,&quot;js_function_name&quot;:&quot;orphalanDiseaseVisit4&quot;}]}]\" id=\"disease-association-4\" data-org-name=\"Il Fondo di Gio ONLUS\" rel=\"noopener noreferrer\"><span class=\"oxy-text-168-356 oxy-text od-link-label\">\nVisit Website\n<\/span><div class=\"oxy-svg-icon2-168-357 oxy-svg-icon2 od-disease-external-icon\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M15 3h6v6\"><\/path><path d=\"M10 14 21 3\"><\/path><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"><\/path><\/svg>\n<\/div><\/a><\/article><\/div><div class=\"oxy-container-168-364 oxy-container od-disease-support-footer\"><a class=\"oxy-container-link-168-363 oxy-container-link od-partner-banner-link\" href=\"\/patient-support-groups\/\" target=\"_self\"><span class=\"oxy-text-168-361 oxy-text od-link-label\">\nBrowse all patient support groups\n<\/span><div class=\"oxy-svg-icon2-168-362 oxy-svg-icon2 od-partner-banner-arrow\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"14\" height=\"14\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M5 12h14\"><\/path><path d=\"m12 5 7 7-7 7\"><\/path><\/svg>\n<\/div><\/a><\/div><\/div><\/div><\/section><section class=\"oxy-container-168-395 oxy-container od-section od-disease-section od-disease-muted\" aria-labelledby=\"disease-steps-title\"><div class=\"oxy-container-168-394 oxy-container od-container\"><div class=\"oxy-container-168-393 oxy-container od-disease-steps-inner\"><header class=\"oxy-container-168-371 oxy-container od-disease-heading od-disease-heading--steps\"><div class=\"oxy-container-168-368 oxy-container od-section-marker\" aria-hidden=\"true\"><\/div><h2 class=\"oxy-text-168-369 oxy-text od-disease-title\" id=\"disease-steps-title\">\nMoving Forward\n<\/h2><p class=\"oxy-text-168-370 oxy-text od-disease-heading-copy\">\nReceiving a glioblastoma diagnosis is a significant and personal experience. These are steps that patients and families often find most helpful in navigating care.\n<\/p><\/header><ol class=\"oxy-container-168-392 oxy-container od-disease-steps\"><li class=\"oxy-container-168-376 oxy-container od-disease-step\"><span class=\"oxy-text-168-372 oxy-text od-disease-step-number\" aria-hidden=\"true\">\n01\n<\/span><div class=\"oxy-container-168-375 oxy-container od-disease-step-copy\"><h3 class=\"oxy-text-168-373 oxy-text od-disease-step-title\">\nEstablish your specialist neuro-oncology team\n<\/h3><p class=\"oxy-text-168-374 oxy-text od-body\">\nGlioblastoma management requires a multidisciplinary team including a neurosurgeon, neuro-oncologist, radiation oncologist, neuropathologist, radiologist and supportive care specialists. If you have not yet been referred to a specialist neuro-oncology centre, ask your treating physician for a referral. A second opinion from a specialist centre is always reasonable.\n<\/p><\/div><\/li><li class=\"oxy-container-168-381 oxy-container od-disease-step\"><span class=\"oxy-text-168-377 oxy-text od-disease-step-number od-disease-step-number--purple\" aria-hidden=\"true\">\n02\n<\/span><div class=\"oxy-container-168-380 oxy-container od-disease-step-copy\"><h3 class=\"oxy-text-168-378 oxy-text od-disease-step-title\">\nUnderstand your tumour's molecular profile\n<\/h3><p class=\"oxy-text-168-379 oxy-text od-body\">\nYour care team will carry out tests on the tumour to look for specific characteristics, including MGMT methylation and IDH mutation status. These results can help guide treatment decisions. Ask your specialist team what the results mean for your individual treatment plan.\n<\/p><\/div><\/li><li class=\"oxy-container-168-386 oxy-container od-disease-step\"><span class=\"oxy-text-168-382 oxy-text od-disease-step-number\" aria-hidden=\"true\">\n03\n<\/span><div class=\"oxy-container-168-385 oxy-container od-disease-step-copy\"><h3 class=\"oxy-text-168-383 oxy-text od-disease-step-title\">\nAsk about clinical trials and emerging treatments\n<\/h3><p class=\"oxy-text-168-384 oxy-text od-body\">\nResearch into glioblastoma is active and ongoing. Ask your neuro-oncologist whether participation in a clinical trial or access to an investigational therapy might be appropriate for your situation. Clinical trial participation may provide access to treatments not yet widely available.\n<\/p><\/div><\/li><li class=\"oxy-container-168-391 oxy-container od-disease-step\"><span class=\"oxy-text-168-387 oxy-text od-disease-step-number od-disease-step-number--purple\" aria-hidden=\"true\">\n04\n<\/span><div class=\"oxy-container-168-390 oxy-container od-disease-step-copy\"><h3 class=\"oxy-text-168-388 oxy-text od-disease-step-title\">\nAccept support and connect with others\n<\/h3><p class=\"oxy-text-168-389 oxy-text od-body\">\nPatient organisations, specialist nurses, psychologists and social workers can provide valuable practical and emotional support. Connecting with others who have experience of glioblastoma \u2014 through patient associations or support groups \u2014 may be a meaningful source of support during treatment and beyond.\n<\/p><\/div><\/li><\/ol><\/div><\/div><\/section><section class=\"oxy-container-168-403 oxy-container od-section od-disease-section od-disease-cta\" aria-labelledby=\"disease-cta-title\"><div class=\"oxy-container-168-402 oxy-container od-container\"><div class=\"oxy-container-168-396 oxy-container od-section-marker\" aria-hidden=\"true\"><\/div><h2 class=\"oxy-text-168-397 oxy-text od-disease-cta-title\" id=\"disease-cta-title\">\nHere to Support You\n<\/h2><p class=\"oxy-text-168-398 oxy-text od-disease-cta-copy\">\nWhether you are a patient or caregiver looking for answers, or a clinician seeking information about our products, our team is ready to support you.\n<\/p><div class=\"oxy-container-168-401 oxy-container od-disease-cta-actions\"><a class=\"oxy-text-link-168-399 oxy-text-link od-disease-cta-primary\" href=\"\/our-approach\/\" target=\"_self\">\nPatient-Centric Approach\n<\/a><a class=\"oxy-text-link-168-400 oxy-text-link od-disease-cta-secondary\" href=\"\/contact\/\" target=\"_self\">\nContact Our Team\n<\/a><\/div><\/div><\/section><aside class=\"oxy-container-168-411 oxy-container od-approval-strip\" aria-label=\"Content approval information\"><div class=\"oxy-container-168-410 oxy-container od-container\"><div class=\"oxy-container-168-409 oxy-container od-approval-layout\"><div class=\"oxy-container-168-407 oxy-container od-approval-code\"><span class=\"oxy-text-168-404 oxy-text od-approval-text\">\nMLR Approval Code: ORP-EU-2026-001\n<\/span><span class=\"oxy-text-168-405 oxy-text od-approval-text\" aria-hidden=\"true\">\n\u2022\n<\/span><span class=\"oxy-text-168-406 oxy-text od-approval-text\">\nApproved: October 2026\n<\/span><\/div><p class=\"oxy-text-168-408 oxy-text od-approval-text\">\nFor Healthcare Professionals and Patients in Europe and regions where Orphalan operates\n<\/p><\/div><\/div><\/aside><dialog class=\"oxy-container-168-421 oxy-container od-leader-dialog od-leader-external\" data-interactions=\"[{&quot;trigger&quot;:&quot;page_loaded&quot;,&quot;actions&quot;:[{&quot;name&quot;:&quot;javascript_function&quot;,&quot;js_function_name&quot;:&quot;orphalanDiseaseInit&quot;}]}]\" id=\"disease-external\" aria-labelledby=\"disease-external-title\" tabindex=\"-1\"><div class=\"oxy-container-168-413 oxy-container od-leader-external-icon\"><div class=\"oxy-svg-icon2-168-412 oxy-svg-icon2 od-leader-value-symbol\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M15 3h6v6\"><\/path><path d=\"M10 14 21 3\"><\/path><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"><\/path><\/svg>\n<\/div><\/div><h2 class=\"oxy-text-168-414 oxy-text od-leader-external-title\" id=\"disease-external-title\">\nYou are leaving orphalan.com\n<\/h2><p class=\"oxy-text-168-415 oxy-text od-body od-leader-external-body\">\nYou are about to visit <strong class=\"od-disease-external-name\" id=\"disease-external-name\">American Brain Tumour Association (ABTA)<\/strong>, an external website. Orphalan is not responsible for the content of external sites.\n<\/p><div class=\"oxy-container-168-418 oxy-container od-pipeline-external-actions\"><a class=\"oxy-text-link-168-416 oxy-text-link od-leader-external-visit od-pipeline-external-action\" href=\"https:\/\/www.abta.org\" target=\"_blank\" data-interactions=\"[{&quot;trigger&quot;:&quot;click&quot;,&quot;prevent_default&quot;:true,&quot;actions&quot;:[{&quot;name&quot;:&quot;javascript_function&quot;,&quot;js_function_name&quot;:&quot;orphalanDiseaseConfirm&quot;}]}]\" id=\"disease-external-visit\" rel=\"noopener noreferrer\">\nVisit Website\n<\/a><button class=\"oxy-text-link-168-417 oxy-text-link od-leader-external-stay od-pipeline-external-action\" target=\"_self\" data-interactions=\"[{&quot;trigger&quot;:&quot;click&quot;,&quot;prevent_default&quot;:true,&quot;actions&quot;:[{&quot;name&quot;:&quot;javascript_function&quot;,&quot;js_function_name&quot;:&quot;orphalanDiseaseClose&quot;}]}]\" id=\"disease-external-stay\" type=\"button\">\nStay on orphalan.com\n<\/button><\/div><button class=\"oxy-container-link-168-420 oxy-container-link od-leader-close od-leader-close--external\" target=\"_self\" data-interactions=\"[{&quot;trigger&quot;:&quot;click&quot;,&quot;prevent_default&quot;:true,&quot;actions&quot;:[{&quot;name&quot;:&quot;javascript_function&quot;,&quot;js_function_name&quot;:&quot;orphalanDiseaseClose&quot;}]}]\" id=\"disease-external-close\" type=\"button\" aria-label=\"Close external site notice\"><div class=\"oxy-svg-icon2-168-419 oxy-svg-icon2 od-leader-close-icon\">\n<svg aria-hidden=\"true\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M18 6 6 18\"><\/path><path d=\"m6 6 12 12\"><\/path><\/svg>\n<\/div><\/button><\/dialog><\/div><\/div><\/main>","protected":false},"excerpt":{"rendered":"<p>Glioblastoma Glioblastoma is one of the most challenging brain tumours diagnosed in adults. Information and support are available for patients and families at every stage. Glioblastoma (GBM) is a fast-growing type of brain cancer and the most common form of aggressive brain cancer in adults. Standard treatment typically includes surgery followed by radiotherapy and chemotherapy, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":126,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_oxygen_hide_in_design_set":false,"_oxygen_tags":"","footnotes":""},"class_list":["post-168","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/funny-fermi.104-248-174-66.plesk.page\/fr\/wp-json\/wp\/v2\/pages\/168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/funny-fermi.104-248-174-66.plesk.page\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/funny-fermi.104-248-174-66.plesk.page\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/funny-fermi.104-248-174-66.plesk.page\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/funny-fermi.104-248-174-66.plesk.page\/fr\/wp-json\/wp\/v2\/comments?post=168"}],"version-history":[{"count":28,"href":"https:\/\/funny-fermi.104-248-174-66.plesk.page\/fr\/wp-json\/wp\/v2\/pages\/168\/revisions"}],"predecessor-version":[{"id":812,"href":"https:\/\/funny-fermi.104-248-174-66.plesk.page\/fr\/wp-json\/wp\/v2\/pages\/168\/revisions\/812"}],"up":[{"embeddable":true,"href":"https:\/\/funny-fermi.104-248-174-66.plesk.page\/fr\/wp-json\/wp\/v2\/pages\/126"}],"wp:attachment":[{"href":"https:\/\/funny-fermi.104-248-174-66.plesk.page\/fr\/wp-json\/wp\/v2\/media?parent=168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}